CStone Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- CStone Pharmaceuticals's estimated annual revenue is currently $48.8M per year.
- CStone Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- CStone Pharmaceuticals has 243 Employees.
- CStone Pharmaceuticals grew their employee count by -8% last year.
CStone Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
CStone Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is CStone Pharmaceuticals?
CStone Pharmaceuticals (HKEX:2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, 5 late-stage candidates are at pivotal trials. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone's vision is to become globally recognized as a leading Chinese biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.
keywords:N/A
N/A
Total Funding
243
Number of Employees
$48.8M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CStone Pharmaceuticals News
SUZHOU, China, April 22, 2022 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("CStone", HKEX: 2616), Servier, today announced the...
... drug company CStone Pharmaceuticals among firms that failed to file results by March 31 deadline; Exchange to keep period of any trading...
CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on research, development, and commercialization of innovative immuno-...
Other Companies in Shanghai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $44.3M | 244 | -9% | N/A |
#2 | $19.1M | 250 | N/A | N/A |
#3 | $33.4M | 253 | 2% | N/A |
#4 | $41.3M | 259 | 3% | N/A |
#5 | $41.3M | 259 | 3% | N/A |